Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study

AIMS: To study whether morphologic (foveal thickness, FT) variations of clinically significant macular oedema (CMO) in patients suffering from diabetes following intravitreal pegaptanib sodium (IVP) injection were associated with functional [macular sensitivity (MS) and colour discrimination (CD)] c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rinaldi, Michele, Chiosi, Flavia, dell'Omo, Roberto, Romano, Mario R, Parmeggiani, Francesco, Semeraro, Francesco, Mastropasqua, Rodolfo, Costagliola, Ciro
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2012
Témata:
Clinical Trials
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3522807/
https://ncbi.nlm.nih.gov/pubmed/22486651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2012.04291.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky